Cerebral Hemodynamic Impairment and Cognitive Dysfunction in APOE4 Carriers With Asymptomatic Carotid Artery Stenosis/Occlusion

Our previous preclinical study demonstrated that -targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than -targeted replacement mice with carotid artery stenosis due to neurovascular dysfunction. Therefore, we clinically investigate whether contributes to c...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Heart Association Vol. 14; no. 6; p. e039210
Main Authors Kakino, Yoshinori, Hattori, Yorito, Ogata, Soshiro, Nakaoku, Yuriko, Nishimura, Kunihiro, Iida, Hidehiro, Ihara, Masafumi
Format Journal Article
LanguageEnglish
Published England John Wiley and Sons Inc 18.03.2025
Wiley
Subjects
Online AccessGet full text
ISSN2047-9980
2047-9980
DOI10.1161/JAHA.124.039210

Cover

Abstract Our previous preclinical study demonstrated that -targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than -targeted replacement mice with carotid artery stenosis due to neurovascular dysfunction. Therefore, we clinically investigate whether contributes to cerebral hemodynamic and cognitive impairment in subjects with asymptomatic carotid artery stenosis or occlusion. A cross-sectional observational study was conducted between January 2017 and March 2022. In a primary analysis, 91 subjects (114 affected cerebral hemispheres) with asymptomatic carotid artery stenosis or occlusion who underwent neuropsychological examinations and O-gas positron emission tomography were included to examine associations of with cognitive impairment and cerebral hemodynamic impairment. A sensitivity analysis was performed with 161 subjects (201 affected cerebral hemispheres) who underwent O-gas positron emission tomography scan. In the primary analysis, 20 (22.0%) subjects were carriers. was an independent risk factor of lower cerebral blood flow in the anterior circulation territory (β=-0.058 [95% CI, -0.098 to -0.018], =0.005) and short-term memory impairment in Alzheimer's Disease Assessment Scale-Cognitive Subscale 13 (β=1.16 [95% CI, 0.009-2.30], =0.048) in a multivariable linear regression analysis. In the sensitivity analysis, 31 (19.3%) subjects carried , which was an independent risk factor of lower cerebral blood flow (β=-0.048 [95% CI, -0.079 to -0.012], =0.003) in the anterior circulation territory. may confer an increased risk of decreased cerebral blood flow accompanied by memory impairment in asymptomatic carotid artery stenosis or occlusion consistent with our experimental study. genotyping in such subjects may be useful for early detection of disease severity.
AbstractList Background Our previous preclinical study demonstrated that APOE4‐targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than APOE3‐targeted replacement mice with carotid artery stenosis due to neurovascular dysfunction. Therefore, we clinically investigate whether APOE4 contributes to cerebral hemodynamic and cognitive impairment in subjects with asymptomatic carotid artery stenosis or occlusion. Methods and Results A cross‐sectional observational study was conducted between January 2017 and March 2022. In a primary analysis, 91 subjects (114 affected cerebral hemispheres) with asymptomatic carotid artery stenosis or occlusion who underwent neuropsychological examinations and 15O‐gas positron emission tomography were included to examine associations of APOE4 with cognitive impairment and cerebral hemodynamic impairment. A sensitivity analysis was performed with 161 subjects (201 affected cerebral hemispheres) who underwent 15O‐gas positron emission tomography scan. In the primary analysis, 20 (22.0%) subjects were APOE4 carriers. APOE4 was an independent risk factor of lower cerebral blood flow in the anterior circulation territory (β=−0.058 [95% CI, −0.098 to −0.018], P=0.005) and short‐term memory impairment in Alzheimer's Disease Assessment Scale‐Cognitive Subscale 13 (β=1.16 [95% CI, 0.009–2.30], P=0.048) in a multivariable linear regression analysis. In the sensitivity analysis, 31 (19.3%) subjects carried APOE4, which was an independent risk factor of lower cerebral blood flow (β=−0.048 [95% CI, −0.079 to −0.012], P=0.003) in the anterior circulation territory. Conclusions APOE4 may confer an increased risk of decreased cerebral blood flow accompanied by memory impairment in asymptomatic carotid artery stenosis or occlusion consistent with our experimental study. APOE genotyping in such subjects may be useful for early detection of disease severity.
Our previous preclinical study demonstrated that APOE4-targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than APOE3-targeted replacement mice with carotid artery stenosis due to neurovascular dysfunction. Therefore, we clinically investigate whether APOE4 contributes to cerebral hemodynamic and cognitive impairment in subjects with asymptomatic carotid artery stenosis or occlusion.BACKGROUNDOur previous preclinical study demonstrated that APOE4-targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than APOE3-targeted replacement mice with carotid artery stenosis due to neurovascular dysfunction. Therefore, we clinically investigate whether APOE4 contributes to cerebral hemodynamic and cognitive impairment in subjects with asymptomatic carotid artery stenosis or occlusion.A cross-sectional observational study was conducted between January 2017 and March 2022. In a primary analysis, 91 subjects (114 affected cerebral hemispheres) with asymptomatic carotid artery stenosis or occlusion who underwent neuropsychological examinations and 15O-gas positron emission tomography were included to examine associations of APOE4 with cognitive impairment and cerebral hemodynamic impairment. A sensitivity analysis was performed with 161 subjects (201 affected cerebral hemispheres) who underwent 15O-gas positron emission tomography scan. In the primary analysis, 20 (22.0%) subjects were APOE4 carriers. APOE4 was an independent risk factor of lower cerebral blood flow in the anterior circulation territory (β=-0.058 [95% CI, -0.098 to -0.018], P=0.005) and short-term memory impairment in Alzheimer's Disease Assessment Scale-Cognitive Subscale 13 (β=1.16 [95% CI, 0.009-2.30], P=0.048) in a multivariable linear regression analysis. In the sensitivity analysis, 31 (19.3%) subjects carried APOE4, which was an independent risk factor of lower cerebral blood flow (β=-0.048 [95% CI, -0.079 to -0.012], P=0.003) in the anterior circulation territory.METHODS AND RESULTSA cross-sectional observational study was conducted between January 2017 and March 2022. In a primary analysis, 91 subjects (114 affected cerebral hemispheres) with asymptomatic carotid artery stenosis or occlusion who underwent neuropsychological examinations and 15O-gas positron emission tomography were included to examine associations of APOE4 with cognitive impairment and cerebral hemodynamic impairment. A sensitivity analysis was performed with 161 subjects (201 affected cerebral hemispheres) who underwent 15O-gas positron emission tomography scan. In the primary analysis, 20 (22.0%) subjects were APOE4 carriers. APOE4 was an independent risk factor of lower cerebral blood flow in the anterior circulation territory (β=-0.058 [95% CI, -0.098 to -0.018], P=0.005) and short-term memory impairment in Alzheimer's Disease Assessment Scale-Cognitive Subscale 13 (β=1.16 [95% CI, 0.009-2.30], P=0.048) in a multivariable linear regression analysis. In the sensitivity analysis, 31 (19.3%) subjects carried APOE4, which was an independent risk factor of lower cerebral blood flow (β=-0.048 [95% CI, -0.079 to -0.012], P=0.003) in the anterior circulation territory.APOE4 may confer an increased risk of decreased cerebral blood flow accompanied by memory impairment in asymptomatic carotid artery stenosis or occlusion consistent with our experimental study. APOE genotyping in such subjects may be useful for early detection of disease severity.CONCLUSIONSAPOE4 may confer an increased risk of decreased cerebral blood flow accompanied by memory impairment in asymptomatic carotid artery stenosis or occlusion consistent with our experimental study. APOE genotyping in such subjects may be useful for early detection of disease severity.
Our previous preclinical study demonstrated that -targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than -targeted replacement mice with carotid artery stenosis due to neurovascular dysfunction. Therefore, we clinically investigate whether contributes to cerebral hemodynamic and cognitive impairment in subjects with asymptomatic carotid artery stenosis or occlusion. A cross-sectional observational study was conducted between January 2017 and March 2022. In a primary analysis, 91 subjects (114 affected cerebral hemispheres) with asymptomatic carotid artery stenosis or occlusion who underwent neuropsychological examinations and O-gas positron emission tomography were included to examine associations of with cognitive impairment and cerebral hemodynamic impairment. A sensitivity analysis was performed with 161 subjects (201 affected cerebral hemispheres) who underwent O-gas positron emission tomography scan. In the primary analysis, 20 (22.0%) subjects were carriers. was an independent risk factor of lower cerebral blood flow in the anterior circulation territory (β=-0.058 [95% CI, -0.098 to -0.018], =0.005) and short-term memory impairment in Alzheimer's Disease Assessment Scale-Cognitive Subscale 13 (β=1.16 [95% CI, 0.009-2.30], =0.048) in a multivariable linear regression analysis. In the sensitivity analysis, 31 (19.3%) subjects carried , which was an independent risk factor of lower cerebral blood flow (β=-0.048 [95% CI, -0.079 to -0.012], =0.003) in the anterior circulation territory. may confer an increased risk of decreased cerebral blood flow accompanied by memory impairment in asymptomatic carotid artery stenosis or occlusion consistent with our experimental study. genotyping in such subjects may be useful for early detection of disease severity.
Author Hattori, Yorito
Ogata, Soshiro
Nakaoku, Yuriko
Nishimura, Kunihiro
Iida, Hidehiro
Kakino, Yoshinori
Ihara, Masafumi
AuthorAffiliation 1 Department of Neurology National Cerebral and Cardiovascular Center Suita, Osaka Japan
2 Department of Preemptive Medicine for Dementia National Cerebral and Cardiovascular Center Suita, Osaka Japan
3 Department of Preventive Medicine and Epidemiology National Cerebral and Cardiovascular Center Suita, Osaka Japan
4 Turku PET Centre University of Turku and Turku General Hospital Turku Finland
AuthorAffiliation_xml – name: 2 Department of Preemptive Medicine for Dementia National Cerebral and Cardiovascular Center Suita, Osaka Japan
– name: 1 Department of Neurology National Cerebral and Cardiovascular Center Suita, Osaka Japan
– name: 4 Turku PET Centre University of Turku and Turku General Hospital Turku Finland
– name: 3 Department of Preventive Medicine and Epidemiology National Cerebral and Cardiovascular Center Suita, Osaka Japan
Author_xml – sequence: 1
  givenname: Yoshinori
  surname: Kakino
  fullname: Kakino, Yoshinori
– sequence: 2
  givenname: Yorito
  orcidid: 0000-0002-1495-4433
  surname: Hattori
  fullname: Hattori, Yorito
– sequence: 3
  givenname: Soshiro
  orcidid: 0000-0002-0100-376X
  surname: Ogata
  fullname: Ogata, Soshiro
– sequence: 4
  givenname: Yuriko
  orcidid: 0000-0002-3100-574X
  surname: Nakaoku
  fullname: Nakaoku, Yuriko
– sequence: 5
  givenname: Kunihiro
  orcidid: 0000-0002-0639-0949
  surname: Nishimura
  fullname: Nishimura, Kunihiro
– sequence: 6
  givenname: Hidehiro
  orcidid: 0000-0002-7914-3068
  surname: Iida
  fullname: Iida, Hidehiro
– sequence: 7
  givenname: Masafumi
  orcidid: 0000-0002-7102-4048
  surname: Ihara
  fullname: Ihara, Masafumi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40079311$$D View this record in MEDLINE/PubMed
BookMark eNpVks9v0zAUxyM0xMbYmRvykUtb_0qcnFCUDVo0qUiAOFqO_dJ5SuxiO5N64l_HpWPafLCf_L76fK3n79vizHkHRfGe4CUhFVl9bdftklC-xKyhBL8qLijmYtE0NT57Vp8XVzHe47wqKljZvCnOOcaiYYRcFH86CNAHNaI1TN4cnJqsRptpr2yYwCWknEGd3zmb7AOg60McZqeT9Q5Zh9pv2xuOOhWChRDRL5vuUBsP0z75SaUMyi2frEFtSBAO6HsC56ONq63W4xwz5V3xelBjhKvH87L4-fnmR7de3G6_bLr2dqE5qdJCV0CMGnhJcS3yxnpR9blQtKkqXPZCq6bWlJGSNkAIGKoHwY1hxHBDQbHLYnPiGq_u5T7YSYWD9MrKfxc-7KQK-cUjSMwNZ0xURuujeVMDCNoz3pclLrmpM-vTibWf-wmMzmPKA3wBfdlx9k7u_IMklDBa1WUmfHwkBP97hpjkZKOGcVQO_BwlI0IQ3pAKZ-mH52ZPLv-_MAtWJ4EOPsYAw5OEYHnMiTzmJHtzecoJ-wvIe7CU
Cites_doi 10.1016/j.neuropsychologia.2008.03.005
10.5853/jos.2023.02733
10.3233/JAD-142874
10.1007/s00401-011-0925-9
10.1159/000090791
10.1109/TNS.2002.807869
10.3389/fpsyg.2012.00301
10.1038/s41593-024-01757-6
10.1002/14651858.CD010632.pub2
10.1177/23969873211026990
10.1038/sj.jcbfm.9600118
10.1212/WNL.0b013e318211c3ae
10.1186/s40658-018-0236-5
10.3389/fncir.2022.916499
10.1136/jnis.2010.002345
10.1016/S1474-4422(21)00359-8
10.1002/trc2.12285
10.1186/s12872-019-1127-y
10.1038/s41467-018-06301-2
10.1016/j.jvs.2005.02.044
10.1371/journal.pone.0146890
10.1097/00002093-199700112-00003
10.3174/ajnr.A6219
10.1088/0031-9155/59/18/5593
10.1007/s13139-019-00633-7
10.1212/WNL.0b013e31824365d3
10.3233/JAD-191073
10.3174/ajnr.A5068
10.1001/archneur.1985.04060030081013
10.1016/j.jstrokecerebrovasdis.2013.03.013
10.1186/s12872-019-1194-0
10.1007/s00401-016-1547-z
10.1038/s41598-019-50681-4
10.1212/WNL.0b013e318295d71a
10.1111/j.1532-5415.2005.53221.x
10.2214/ajr.149.2.351
10.1038/s41598-022-09129-5
10.3174/ajnr.A3799
10.1007/s11682-023-00764-8
10.3389/fpsyg.2018.00765
10.1016/j.jvs.2017.04.038
10.1007/s00401-018-1862-7
10.1161/STROKEAHA.124.047160
ContentType Journal Article
Copyright 2025 The Author(s). Published on behalf of the American Heart Association, Inc., by Wiley.
Copyright_xml – notice: 2025 The Author(s). Published on behalf of the American Heart Association, Inc., by Wiley.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1161/JAHA.124.039210
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate APOE4 and Carotid Artery Stenosis/Occlusion
EISSN 2047-9980
ExternalDocumentID oai_doaj_org_article_04d43376dccc41698ee72b34b55054d8
PMC12132685
40079311
10_1161_JAHA_124_039210
Genre Journal Article
Observational Study
GroupedDBID 0R~
1OC
24P
53G
5VS
8-1
AAMMB
AAYXX
AAZKR
ACCMX
ACGFO
ACXQS
ADBBV
ADKYN
ADZMN
AEFGJ
AEGXH
AENEX
AGXDD
AIAGR
AIDQK
AIDYY
ALAGY
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AVUZU
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GODZA
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
RAH
RNS
RPM
WIN
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c416t-c6e1daf4520875203b76b752a296605b7ca98c231529e11ed2cf74dd31d4d2ea3
IEDL.DBID DOA
ISSN 2047-9980
IngestDate Wed Aug 27 01:25:52 EDT 2025
Thu Aug 21 18:25:42 EDT 2025
Fri Sep 05 07:52:30 EDT 2025
Mon Jul 21 06:01:37 EDT 2025
Tue Aug 05 12:03:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords cerebral blood flow
carotid artery stenosis
memory
APOE4
carotid artery occlusion
Language English
License This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c416t-c6e1daf4520875203b76b752a296605b7ca98c231529e11ed2cf74dd31d4d2ea3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
This article was sent to Neel S. Singhal, MD, PhD, Associate Editor, for review by expert referees, editorial decision, and final disposition.
Supplemental Material is available at https://www.ahajournals.org/doi/suppl/10.1161/JAHA.124.039210
Y. Kakino and Y. Hattori contributed equally to this article.
For Sources of Funding and Disclosures, see page 12.
ORCID 0000-0002-1495-4433
0000-0002-7102-4048
0000-0002-0100-376X
0000-0002-0639-0949
0000-0002-7914-3068
0000-0002-3100-574X
OpenAccessLink https://doaj.org/article/04d43376dccc41698ee72b34b55054d8
PMID 40079311
PQID 3177149160
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_04d43376dccc41698ee72b34b55054d8
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12132685
proquest_miscellaneous_3177149160
pubmed_primary_40079311
crossref_primary_10_1161_JAHA_124_039210
PublicationCentury 2000
PublicationDate 2025-03-18
PublicationDateYYYYMMDD 2025-03-18
PublicationDate_xml – month: 03
  year: 2025
  text: 2025-03-18
  day: 18
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Hoboken
PublicationTitle Journal of the American Heart Association
PublicationTitleAlternate J Am Heart Assoc
PublicationYear 2025
Publisher John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley and Sons Inc
– name: Wiley
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_48_2
e_1_3_2_29_2
e_1_3_2_41_2
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_42_2
e_1_3_2_22_2
e_1_3_2_45_2
e_1_3_2_23_2
e_1_3_2_44_2
e_1_3_2_24_2
e_1_3_2_47_2
e_1_3_2_25_2
e_1_3_2_46_2
Iida H (e_1_3_2_21_2) 1993; 34
e_1_3_2_9_2
e_1_3_2_15_2
Koga M (e_1_3_2_16_2) 2001; 22
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
Rosner J (e_1_3_2_28_2) 2023
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
References_xml – ident: e_1_3_2_36_2
  doi: 10.1016/j.neuropsychologia.2008.03.005
– ident: e_1_3_2_27_2
  doi: 10.5853/jos.2023.02733
– volume: 34
  start-page: 1333
  year: 1993
  ident: e_1_3_2_21_2
  article-title: Modeling approach to eliminate the need to separate arterial plasma in oxygen‐15 inhalation positron emission tomography
  publication-title: J Nucl Med
– ident: e_1_3_2_47_2
  doi: 10.3233/JAD-142874
– ident: e_1_3_2_41_2
  doi: 10.1007/s00401-011-0925-9
– ident: e_1_3_2_2_2
  doi: 10.1159/000090791
– ident: e_1_3_2_20_2
  doi: 10.1109/TNS.2002.807869
– ident: e_1_3_2_35_2
  doi: 10.3389/fpsyg.2012.00301
– ident: e_1_3_2_13_2
  doi: 10.1038/s41593-024-01757-6
– ident: e_1_3_2_48_2
  doi: 10.1002/14651858.CD010632.pub2
– ident: e_1_3_2_17_2
  doi: 10.1177/23969873211026990
– ident: e_1_3_2_19_2
  doi: 10.1038/sj.jcbfm.9600118
– ident: e_1_3_2_31_2
  doi: 10.1212/WNL.0b013e318211c3ae
– ident: e_1_3_2_18_2
  doi: 10.1186/s40658-018-0236-5
– ident: e_1_3_2_32_2
  doi: 10.3389/fncir.2022.916499
– ident: e_1_3_2_25_2
  doi: 10.1136/jnis.2010.002345
– ident: e_1_3_2_4_2
  doi: 10.1016/S1474-4422(21)00359-8
– ident: e_1_3_2_40_2
  doi: 10.1002/trc2.12285
– ident: e_1_3_2_8_2
  doi: 10.1186/s12872-019-1127-y
– ident: e_1_3_2_12_2
  doi: 10.1038/s41467-018-06301-2
– ident: e_1_3_2_11_2
– ident: e_1_3_2_15_2
  doi: 10.1016/j.jvs.2005.02.044
– ident: e_1_3_2_39_2
  doi: 10.1371/journal.pone.0146890
– ident: e_1_3_2_24_2
  doi: 10.1097/00002093-199700112-00003
– ident: e_1_3_2_37_2
  doi: 10.3174/ajnr.A6219
– ident: e_1_3_2_22_2
  doi: 10.1088/0031-9155/59/18/5593
– ident: e_1_3_2_3_2
  doi: 10.1007/s13139-019-00633-7
– ident: e_1_3_2_6_2
  doi: 10.1212/WNL.0b013e31824365d3
– ident: e_1_3_2_44_2
  doi: 10.3233/JAD-191073
– ident: e_1_3_2_46_2
  doi: 10.3174/ajnr.A5068
– ident: e_1_3_2_33_2
  doi: 10.1001/archneur.1985.04060030081013
– ident: e_1_3_2_30_2
  doi: 10.1016/j.jstrokecerebrovasdis.2013.03.013
– ident: e_1_3_2_29_2
  doi: 10.1186/s12872-019-1194-0
– volume-title: StatPearls
  year: 2023
  ident: e_1_3_2_28_2
– ident: e_1_3_2_10_2
  doi: 10.1007/s00401-016-1547-z
– ident: e_1_3_2_42_2
  doi: 10.1038/s41598-019-50681-4
– ident: e_1_3_2_5_2
  doi: 10.1212/WNL.0b013e318295d71a
– ident: e_1_3_2_23_2
  doi: 10.1111/j.1532-5415.2005.53221.x
– volume: 22
  start-page: 413
  year: 2001
  ident: e_1_3_2_16_2
  article-title: Diagnosis of internal carotid artery stenosis greater than 70% with power Doppler duplex sonography
  publication-title: Am J Neuroradiol
– ident: e_1_3_2_26_2
  doi: 10.2214/ajr.149.2.351
– ident: e_1_3_2_14_2
  doi: 10.1038/s41598-022-09129-5
– ident: e_1_3_2_45_2
  doi: 10.3174/ajnr.A3799
– ident: e_1_3_2_38_2
  doi: 10.1007/s11682-023-00764-8
– ident: e_1_3_2_34_2
  doi: 10.3389/fpsyg.2018.00765
– ident: e_1_3_2_7_2
  doi: 10.1016/j.jvs.2017.04.038
– ident: e_1_3_2_43_2
  doi: 10.1007/s00401-018-1862-7
– ident: e_1_3_2_9_2
  doi: 10.1161/STROKEAHA.124.047160
SSID ssj0000627359
Score 2.3814402
Snippet Our previous preclinical study demonstrated that -targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than -targeted...
Our previous preclinical study demonstrated that APOE4-targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than...
Background Our previous preclinical study demonstrated that APOE4‐targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e039210
SubjectTerms Aged
APOE4
Apolipoprotein E4 - genetics
Asymptomatic Diseases
carotid artery occlusion
carotid artery stenosis
Carotid Stenosis - complications
Carotid Stenosis - diagnosis
Carotid Stenosis - diagnostic imaging
Carotid Stenosis - genetics
Carotid Stenosis - physiopathology
Carotid Stenosis - psychology
cerebral blood flow
Cerebrovascular Circulation - physiology
Cognition
Cognitive Dysfunction - diagnosis
Cognitive Dysfunction - etiology
Cognitive Dysfunction - genetics
Cognitive Dysfunction - physiopathology
Cross-Sectional Studies
Female
Hemodynamics
Heterozygote
Humans
Male
memory
Middle Aged
Original Research
Positron-Emission Tomography
Risk Factors
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQIiEuiDflJSNx4JLdxHYc54BQKbsqK5VFgoq9WX6FjdRNliSV6Im_zkySLhT1yC2Kk4zjL-OZ8TjfEPJaWSMcZhiDkiISnBWRKQToVWx9apSzpierXnyS86U4PU_P_5QDGgew3RvaYT2pZbM6_Plj8w4U_m2v8DI5Op3OcU1PHIJMhr9b3QSzJDESW4y-_jAtg6VO85HeZ899O5apJ_Df53X-u3nyL2t0cpfcGd1IOh1wv0duhOo-ubUYE-UPyK9ZaDAlvKLzcFn7oew8_Qi6Xza4HkhN5elsu3WIfti0aOAQJFpWdPr57FjQmWmwnF1Lv5XdBZ22m8urru4ZXrGp7kqP8kOzoV86pBwv26Mz51ZrXH97SJYnx19n82istRA5GKsucjIkHlBKGVLcs5jbTFo4AKgkRDw2cyZXDpzBlOUhSYJnrsiE9zzxwrNg-CNyUNVVeEJo4V1ucsOtt5mIRaGU9TH3-OxCBusn5M12nPXVQKmh-1BEJhoh0QCJHiCZkPeIw_VlyIXdn6ib73pULR0LLzjMk945fJdchZAxy4XF4Et4NSGvtihq0B1MiJgq1OtWg--UQYSYSBD0eED1WhTWi895kkyI2sF7py-7LVV50fNzI0sekyp9-j96_4zcZlhyGLcQqufkoGvW4QX4QZ192X_fvwFflghV
  priority: 102
  providerName: Scholars Portal
Title Cerebral Hemodynamic Impairment and Cognitive Dysfunction in APOE4 Carriers With Asymptomatic Carotid Artery Stenosis/Occlusion
URI https://www.ncbi.nlm.nih.gov/pubmed/40079311
https://www.proquest.com/docview/3177149160
https://pubmed.ncbi.nlm.nih.gov/PMC12132685
https://doaj.org/article/04d43376dccc41698ee72b34b55054d8
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9JL6bubPlChh17ctWVZlo_bbcI2sE2hDc1NSBqZGBI72N7DnvrXO2N7w24p9NKLMZaxBn0az6fXN4y9185KTyuMQSsZyVSUkS0l-lXsILPaOzuIVa-_qtWFPLvMLvdSfdGesFEeeGy4eSxBpugF4L1H8lDoEHLhUumIWksYjvnGRbw3mBr_wRiWs2LS8kFWMz9brGjiT35EwwSdl90LQ4Na_98o5p87JfdCz-kj9nDijHwx2vqY3Qv1E3Z_Pa2KP2W_lqGl9d9rvgo3DYw55vkXdPSqpck_bmvgy90-If5521E0I0R4VfPFt_MTyZe2pdx1Hf9Z9Vd80W1vbvtmkHOloqavgOoP7ZZ_70lfvOrm595fb2iy7Rm7OD35sVxFU2KFiJqwj7wKCSAkmSA9exGnLlcObxAXhcMbl3tbaI_MLxNFSJIAwpe5BEgTkCCCTZ-zo7qpw0vGS_CFLWzqwOUylqXWDuIU6NulCg5m7MOunc3tqJ9hhnGHSgxBYhASM0IyY58Ih7vXSPh6eIDdwUzdwfyrO8zYux2KBh2FVj9sHZpNZ5Ao5TgcTBRW9GJE9a4qSg5fpEkyY_oA7wNbDkvq6moQ4yZJPKF0dvw_rH_FHgjKL0z7BfVrdtS3m_AGSU_v3g79G69rqX8DYSABxw
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cerebral+Hemodynamic+Impairment+and+Cognitive+Dysfunction+in+APOE4+Carriers+With+Asymptomatic+Carotid+Artery+Stenosis%2FOcclusion&rft.jtitle=Journal+of+the+American+Heart+Association&rft.au=Yoshinori+Kakino&rft.au=Yorito+Hattori&rft.au=Soshiro+Ogata&rft.au=Yuriko+Nakaoku&rft.date=2025-03-18&rft.pub=Wiley&rft.eissn=2047-9980&rft.volume=14&rft.issue=6&rft_id=info:doi/10.1161%2FJAHA.124.039210&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_04d43376dccc41698ee72b34b55054d8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-9980&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-9980&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-9980&client=summon